Pharmacokinetics, pharmacodynamics and safety of intra-articular multiple doses of 500 mcg icatibant in an uncontrolled 13-week multi-center study in patients with symptomatic knee osteoarthritis
Latest Information Update: 11 Aug 2011
At a glance
- Drugs Icatibant (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics
- Acronyms TRICAPEKA
- 11 Aug 2011 New trial record